Article
Confirming putative variants at ≤ 5% allele frequency using allele enrichment and Sanger sequencing.
Scientific reports - 2 Jun 2021
Yan Yan Helen, Chen Sherry X, Cheng Lauren Y, Rodriguez Alyssa Y, Tang Rui, Cabrera Karina, Zhang David Yu
Abstract excerpt
Whole exome sequencing (WES) is used to identify mutations in a patient's tumor DNA that are predictive of tumor behavior, including the likelihood of response or resistance to cancer therapy. WES has a mutation limit of detection (LoD) at variant allele frequencies (VAF) of 5%. Putative mutations called at ≤ 5% VAF are frequently due to sequencing errors, therefore reporting these subclonal mutations incurs risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
